Department of Medicine II, Klinikum Grosshadern, University of Munich, Munich, Germany.
Hepatology. 2010 Apr;51(4):1095-106. doi: 10.1002/hep.23472.
A review is presented of Gustav Paumgartner's five decades of research and practice in hepatology focusing on biliary physiology and disease. It begins with studies of the excretory function of the liver including hepatic uptake of indocyanine green, bilirubin, and bile acids. The implications of these studies for diagnosis and understanding of liver diseases are pointed out. From there, the path of scientific research leads to investigations of hepatobiliary bile acid transport and the major mechanisms of bile formation. The therapeutic effects of the hydrophilic bile acid, ursodeoxycholic acid, have greatly stimulated these studies. Although ursodeoxycholic acid therapy for dissolution of cholesterol gallstones and some other nonsurgical treatments of gallstones were largely superseded by surgical techniques, ursodeoxycholic acid is currently considered the mainstay of therapy of some chronic cholestatic liver diseases, such as primary biliary cirrhosis. The major mechanisms of action of ursodeoxycholic acid therapy in cholestatic liver diseases are discussed. An attempt is made to illustrate how scientific research can lead to advances in medical practice that help patients.
本文回顾了古斯塔夫·保曼(Gustav Paumgartner)在肝胆科学领域 50 年的研究和实践,重点关注胆生理和胆疾病。本文首先介绍了肝脏的排泄功能研究,包括肝脏对靛氰绿、胆红素和胆汁酸的摄取。指出了这些研究对肝脏疾病的诊断和理解的意义。然后,科学研究的方向转向了对肝胆胆汁酸转运和胆汁形成的主要机制的研究。亲水性胆汁酸熊去氧胆酸的治疗效果极大地刺激了这些研究。尽管熊去氧胆酸溶解胆固醇结石的治疗以及其他一些非手术治疗胆结石的方法已在很大程度上被手术技术所取代,但熊去氧胆酸目前被认为是治疗原发性胆汁性肝硬化等一些慢性胆汁淤积性肝病的主要治疗方法。本文讨论了熊去氧胆酸治疗胆汁淤积性肝病的主要作用机制。本文试图说明科学研究如何能够促进医疗实践的进步,从而帮助患者。